Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The global veterinary molecular diagnostics market size is expected to be valued at US$ 194.47 million in 2023, surpassing US$ 377.22 million by 2033. The demand for veterinary molecular diagnostics is projected to grow at a CAGR of 6.84% between 2023 and 2033.
The growth can be attributed to:
Rising Pet Adoption and Animal Health Expenditure to Become Key Trends in the Veterinary Molecular Diagnostics Industry
As of 2022, more than 61% of the United States population owned a pet/companion animal. There is an increasing trend of treating pets as family members, which has increased the healthcare demands for veterinary applications. The increasing pet population is one of the reasons for the rising health expenditure on animals, globally.
The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for animals, for various disease conditions. Also, there is an increase in the livestock population, owing to the huge demand for animal-derived products. This is expected to increase the demand for molecular diagnostic tests in the next coming years.
Untapped Emerging Markets to Accelerate the Adoption of Veterinary Molecular Diagnostics
The emerging economies are expected to become a focal point for the growth of the veterinary diagnostics market. The Asia Pacific, Middle Eastern, and Latin American regions are relatively untapped markets for companies compared to Europe and North America.
Large poultry and dairy animal populations in these emerging markets are expected to drive the growth of the veterinary health market. Currently, the number of veterinarians in emerging markets is on the rise.
Emerging countries like India and China have robust livestock markets. According to the Livestock Production Statistics of India 2018, India is one of the largest milk producers (20.17% of the global production), followed by the United States, China, Brazil, and Pakistan.
Further, many veterinary practices are adopting technologically advanced solutions commonly used by veterinarians in developed economies. Thus, with a surge in the companion animal population, growing demand for veterinary services from the livestock industry, and growing companion animal health expenditure, emerging countries across the Asia Pacific and Latin America are expected to offer significant growth opportunities for the market.
High Cost Associated with the Rising Pet Care to Limit the Market Growth
In the last ten years, pet care costs have increased significantly. According to the APPA 2019 report, veterinary care is the second-highest source of spending in the pet care community. The United States, for example, spent over US$ 18.11 billion on veterinary care in 2018, a growth of 6.1% over the previous year. This is expected to reach US$ 19.98 billion in 2019.
Advanced products and procedures play a significant role in treatments. However, the cost of materials and equipment used in these procedures is very high. For instance, diagnostic procedures for identifying sensitivity to antimicrobials, or the presence of infection using PCR or any other advanced technologies, are costlier than the actual treatment. Hence, pet owners and veterinarians are reluctant to invest so much for diagnostic purposes.
Data Points | Key Statistics |
---|---|
Veterinary Molecular Diagnostics Market Value 2023 | US$ 194.47 million |
Veterinary Molecular Diagnostics Market Projected Value (2033) | US$ 377.22 million |
Veterinary Molecular Diagnostics Market CAGR (2023 to 2033) | 6.84% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In 2018, the market represented revenue of US$ 127.69 million. From 2018 to 2022, sales witnessed significant growth, registering a CAGR of 7.3%.
During the historical period of 2018 to 2022, the veterinary molecular diagnostics market experienced steady growth due to the increasing prevalence of zoonotic diseases. Including growing awareness among pet owners about animal health, and advancements in molecular diagnostic techniques. In addition, the rising demand for animal-derived food products and the need for early disease diagnosis in livestock have also contributed to the growth of this market.
The global demand for veterinary molecular diagnostics is projected to increase at a CAGR of 6.84% during the forecast period between 2022 and 2033. The market is anticipated to reach a total of US$ 377.22 million in 2033.
Moving forward, the global veterinary molecular diagnostics market is expected to continue its growth trajectory due to the increasing adoption of pets, the growing awareness about animal health, and the rising prevalence of zoonotic diseases. Additionally, the development of novel molecular diagnostic techniques and the emergence of advanced technologies such as next-generation sequencing is also expected to drive market growth.
The market is expected to face challenges such as the high cost associated with molecular diagnostic tests and the lack of skilled professionals in this field. Nonetheless, the increasing prevalence of zoonotic diseases and the rising demand for early disease diagnosis in animals are expected to be the key drivers of market growth.
Veterinary Molecular Diagnostics Market:
Attributes | Veterinary Molecular Diagnostics Market |
---|---|
CAGR (2023 to 2033) | 6.84% |
Market Value (2033) | US$ 377.22 million |
Opportunity | Increasing adoption of pets and rising prevalence of zoonotic diseases |
Key Trends | Development of novel molecular diagnostic techniques and the emergence of advanced technologies such as next-generation sequencing |
Viral Molecular Diagnostics Market:
Attributes | Viral Molecular Diagnostics Market |
---|---|
CAGR (2023 to 2033) | 10% |
Market Value (2033) | US$ 32.4 billion |
Opportunity | Growing demand for early diagnosis of viral diseases |
Key Trends | Increasing use of PCR-based tests for rapid and accurate diagnosis of viral infections |
Automated Molecular Diagnostics Testing System Market:
Attributes | Automated Molecular Diagnostics Testing System Market |
---|---|
CAGR (2023 to 2033) | 5.6% |
Market Value (2033) | US$ 51 billion |
Opportunity | Rising demand for high-throughput and automated diagnostic systems |
Key Trends | Development of compact and user-friendly automated diagnostic systems with advanced features such as AI and data management |
The veterinary molecular diagnostics market in the United States is expected to accumulate the highest market share of 34.6% in 2022. The United States is expected to dominate the market, attributed to factors, such as rising pet adoption and increasing per capita animal healthcare expenditure. In addition, the rise in the prevalence of various animal diseases and injuries is another major factor that is anticipated to fuel the market growth during the forecast period.
In addition, the presence of major players is one of the major factors contributing to the dominance of the country in the global veterinary molecular diagnostics industry. Moreover, rising awareness about animal wellness and increasing efforts by organizations to promote animal welfare activities in the United States are further promoting the growth of the market in the nation.
The veterinary molecular diagnostics market in Germany is expected to accumulate a market share of 9.5% in 2023. The regional market is expected to continue to maintain the trend over the forecast period as well.
Germany is the second-most lucrative country in the global veterinary molecular diagnostics industry, behind the US. Increased government backing, high-quality diagnostic procedures, and the number of veterinary diagnostic centers are the major factors that are expected to escalate the growth of the veterinary molecular diagnostics industry grow in Germany.
High usage of superior-quality diagnostics techniques and active government support are some other factors that are likely to propel the growth of the veterinary molecular diagnostics industry in Germany during the forecast period.
The veterinary molecular diagnostics market in India is expected to accumulate a market share value of 5% in 2023. India is expected to register significant growth over the forecast period owing to the increase in the number of diagnostic laboratories, government and private funding for veterinary health care activities, and rising awareness about veterinary molecular diagnostics in the region.
In addition, the rapidly rising animal population and high adoption of veterinary diagnostic products within the country are some other factors that are anticipated to fuel the growth of the veterinary molecular diagnostics market in India over the analysis period.
PCR Kits are estimated to account for the largest market share of 50.8% of the veterinary molecular diagnostics industry in 2023. Polymerase Chain Reaction (PCR) is widely used for molecular diagnosis in animals for the identification and detection of various pathogens. Traditional PCR techniques are rapidly being replaced by real-time PCR.
The PCR kits segment is driving the market growth, owing to factors such as the increasing need for quick result-generating tests, growing research studies for the development of new DNA and RNA-based therapies, and others.
In addition, the increasing adulteration of food products and the growing need for accurate diagnosis are some other factors that are expected to fuel the growth of the PCR Kits segment of the veterinary molecular diagnostics market in the forthcoming years.
Based on the species type, the livestock animals segment is expected to witness a significant growth of 71.0% in 2023. This growth is attributed to the rising number of companion animals across the globe. The sales are also propelled by the willingness of owners to spend more on their pets, the rising adoption of pet insurance, and the availability of cheaper and easy-to-use POC diagnostic tests for companion animals.
Moreover, infectious diseases cause a loss of production capacity in livestock animals. Therefore, governments across the globe are heavily focusing on increasing awareness about these diseases by undertaking initiatives related to diagnosis. Also, governments are working with domestic and international partners to promote animal health products. These initiatives help educate decision-makers, regulatory agencies, reference laboratories, and other end-users regarding the importance of livestock diagnosis.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Startups in the veterinary molecular diagnostics industry such as Basepaws, Embark Veterinary, and AnimalBiome are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interest of potential buyers and creating a larger customer base. For instance,
Basepaws is a cat genetic testing company that was established in 2018. The client must collect a sample of the cat hair and ship it to the business's laboratory for sequencing to use the service. The business examines the DNA sequence and produces a report that details the genetic composition (mix of varieties). The business utilizes genetic information to build a cross-species library of genotypic and phenotypic information that will probably be used to support translational research and comparative medicine.
Embark Veterinary, which was founded in 2015, offers DNA test kits for dogs that help dog owners provide their pets with better care. More than 200,000 genetic markers are tracked by the test. Also, it offers dog owners an app via which they can schedule a visit from the Embark team and learn more about the test kit.
AnimalBiome is a supplier of diagnostic services based on the animal microbiome for the care of pets. Customers can send samples through an evaluation kit to extract and analyze DNA to understand the gut microbiota of their pets. They deliver an analysis report that also has a tool for comparing gut health and flags any unusual patterns in the data.
Who are the Leading Players in the Veterinary Molecular Diagnostics Market?
The veterinary molecular diagnostics industry is highly competitive, with several key players dominating the market. Companies such as IDEXX Laboratories, VCA Antech, Zoetis, and Thermo Fisher Scientific hold a significant market share and are continuously innovating to maintain their positions. Smaller players in the market are also making their mark by developing niche solutions to cater to specific veterinary needs.
One of the main challenges faced by companies in the veterinary molecular diagnostics industry is the high cost associated with developing and launching new diagnostic solutions. Additionally, strict regulations and approval processes by regulatory bodies such as the FDA and USDA can pose a challenge for companies looking to enter the market.
The growing demand for molecular diagnostic solutions for pets and livestock presents a significant investment opportunity for new entrants in the market. The rise in pet ownership and increasing awareness regarding animal health has led to a surge in demand for innovative diagnostic solutions. Companies focusing on developing cost-effective, accurate, and user-friendly diagnostic tools for veterinarians can potentially carve out a niche for themselves in the market. Furthermore, strategic collaborations and partnerships with established players can help new entrants gain a foothold in the competitive landscape.
Recent Developments:
How Companies can Scale Their Businesses in the Veterinary Molecular Diagnostics Market?
Businesses can increase their foothold in the market by investing in research and development to develop innovative products that can meet the growing demand for more accurate and efficient diagnostic tests. This can include developing new tests that can detect a wider range of diseases or improving existing tests to provide faster and more reliable results.
Companies can also scale their businesses by forming strategic partnerships with other companies in the industry. This can include partnering with biotech companies to develop new products or with veterinary clinics to expand their customer base.
Companies can also scale their businesses by expanding into emerging markets where there is a growing demand for veterinary diagnostic tests. This can include countries in Asia, Latin America, and Africa where the demand for animal products is rising due to population growth and increasing urbanization. By expanding into these markets, companies can tap into new sources of revenue and gain a competitive advantage over their rivals.
Businesses can also expand by adopting digital technologies such as telemedicine and remote monitoring. This can enable companies to provide more convenient and cost-effective diagnostic services to their customers, while also improving the accuracy and speed of their tests. By embracing these technologies, companies can stay ahead of the curve and position themselves as leaders in the industry.
Finally, companies can scale their businesses by investing in talent and training to attract and retain the best employees in the industry. This can include providing ongoing training and development opportunities to ensure that employees are up-to-date on the latest developments in the field. By investing in talent and training, companies can build a strong and skilled workforce that can help them grow and innovate in the Veterinary Molecular Diagnostics market.
Report Attribute | Details |
---|---|
Growth Rate | CAGR of 6.84% from 2023 to 2033 |
Market Value in 2022 | US$ 194.47 million |
Market Value in 2033 | US$ 377.22 million |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | Revenue in US$ million and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
The market is valued at US$ 194.47 million in 2023.
IDEXX Laboratories and Thermo Fisher Scientific Inc. are key market players.
The livestock animals segment is likely to remain preferred through 2033.
Players opt for mergers and acquisitions.
India, Japan, and China dominate the Asian market.
1. Executive Summary | Veterinary Molecular Diagnostics Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033 5.3.1. PCR Kits 5.3.1.1. RT-PCR Kits 5.3.1.2. RAPD-PCR Kits 5.3.2. INAAT Kits 5.3.3. Microarray Kits 5.3.4. DNA Sequencing Kits 5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Disease, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease, 2023 to 2033 6.3.1. Anaplasma spp. 6.3.2. Ehrlichia spp. 6.3.3. New Castle Disease 6.3.4. Influenza 6.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS) 6.3.6. Others 6.4. Y-o-Y Growth Trend Analysis By Disease, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Disease, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Species 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Species, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Species, 2023 to 2033 7.3.1. Livestock Animals 7.3.1.1. Porcine 7.3.1.2. Poultry 7.3.1.3. Bovine/Cattle 7.3.1.4. Aquatic 7.3.1.5. Ovine 7.3.2. Companion Animals 7.3.2.1. Canine 7.3.2.2. Feline 7.3.2.3. Avian 7.4. Y-o-Y Growth Trend Analysis By Species, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Species, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022 8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033 8.3.1. Veterinary Hospitals 8.3.2. Clinical Laboratories 8.3.3. Veterinary Research Institutes 8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022 8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Product 10.2.3. By Disease 10.2.4. By Species 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product 10.3.3. By Disease 10.3.4. By Species 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Product 11.2.3. By Disease 11.2.4. By Species 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product 11.3.3. By Disease 11.3.4. By Species 11.3.5. By End User 11.4. Key Takeaways 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UNITED KINGDOM 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Product 12.2.3. By Disease 12.2.4. By Species 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product 12.3.3. By Disease 12.3.4. By Species 12.3.5. By End User 12.4. Key Takeaways 13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Malaysia 13.2.1.3. Singapore 13.2.1.4. Thailand 13.2.1.5. Rest of South Asia 13.2.2. By Product 13.2.3. By Disease 13.2.4. By Species 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product 13.3.3. By Disease 13.3.4. By Species 13.3.5. By End User 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product 14.2.3. By Disease 14.2.4. By Species 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product 14.3.3. By Disease 14.3.4. By Species 14.3.5. By End User 14.4. Key Takeaways 15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. Australia 15.2.1.2. New Zealand 15.2.2. By Product 15.2.3. By Disease 15.2.4. By Species 15.2.5. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product 15.3.3. By Disease 15.3.4. By Species 15.3.5. By End User 15.4. Key Takeaways 16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Product 16.2.3. By Disease 16.2.4. By Species 16.2.5. By End User 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Product 16.3.3. By Disease 16.3.4. By Species 16.3.5. By End User 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2022 17.1.2.1. By Product 17.1.2.2. By Disease 17.1.2.3. By Species 17.1.2.4. By End User 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2022 17.2.2.1. By Product 17.2.2.2. By Disease 17.2.2.3. By Species 17.2.2.4. By End User 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2022 17.3.2.1. By Product 17.3.2.2. By Disease 17.3.2.3. By Species 17.3.2.4. By End User 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2022 17.4.2.1. By Product 17.4.2.2. By Disease 17.4.2.3. By Species 17.4.2.4. By End User 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2022 17.5.2.1. By Product 17.5.2.2. By Disease 17.5.2.3. By Species 17.5.2.4. By End User 17.6. UNITED KINGDOM 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2022 17.6.2.1. By Product 17.6.2.2. By Disease 17.6.2.3. By Species 17.6.2.4. By End User 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2022 17.7.2.1. By Product 17.7.2.2. By Disease 17.7.2.3. By Species 17.7.2.4. By End User 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2022 17.8.2.1. By Product 17.8.2.2. By Disease 17.8.2.3. By Species 17.8.2.4. By End User 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2022 17.9.2.1. By Product 17.9.2.2. By Disease 17.9.2.3. By Species 17.9.2.4. By End User 17.10. India 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2022 17.10.2.1. By Product 17.10.2.2. By Disease 17.10.2.3. By Species 17.10.2.4. By End User 17.11. Malaysia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2022 17.11.2.1. By Product 17.11.2.2. By Disease 17.11.2.3. By Species 17.11.2.4. By End User 17.12. Singapore 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2022 17.12.2.1. By Product 17.12.2.2. By Disease 17.12.2.3. By Species 17.12.2.4. By End User 17.13. Thailand 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2022 17.13.2.1. By Product 17.13.2.2. By Disease 17.13.2.3. By Species 17.13.2.4. By End User 17.14. China 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2022 17.14.2.1. By Product 17.14.2.2. By Disease 17.14.2.3. By Species 17.14.2.4. By End User 17.15. Japan 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2022 17.15.2.1. By Product 17.15.2.2. By Disease 17.15.2.3. By Species 17.15.2.4. By End User 17.16. South Korea 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2022 17.16.2.1. By Product 17.16.2.2. By Disease 17.16.2.3. By Species 17.16.2.4. By End User 17.17. Australia 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2022 17.17.2.1. By Product 17.17.2.2. By Disease 17.17.2.3. By Species 17.17.2.4. By End User 17.18. New Zealand 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2022 17.18.2.1. By Product 17.18.2.2. By Disease 17.18.2.3. By Species 17.18.2.4. By End User 17.19. GCC Countries 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2022 17.19.2.1. By Product 17.19.2.2. By Disease 17.19.2.3. By Species 17.19.2.4. By End User 17.20. South Africa 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2022 17.20.2.1. By Product 17.20.2.2. By Disease 17.20.2.3. By Species 17.20.2.4. By End User 17.21. Israel 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2022 17.21.2.1. By Product 17.21.2.2. By Disease 17.21.2.3. By Species 17.21.2.4. By End User 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Product 18.3.3. By Disease 18.3.4. By Species 18.3.5. By End User 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. bioMérieux SA 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.2. IDEXX Laboratories, Inc. 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.3. Neogen Europe, Ltd. 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.4. Veterinary Molecular Diagnostics, Inc. 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.5. Thermo Fisher Scientific, Inc. 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.6. Qiagen N.V. 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.7. Zoetis 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.8. Heska Corp. 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.9. Agrolabo S.p.A. 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.10. Covetrus 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Disease, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Species, 2018 to 2033 Table 5: Global Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Disease, 2018 to 2033 Table 9: North America Market Value (US$ Million) Forecast by Species, 2018 to 2033 Table 10: North America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 13: Latin America Market Value (US$ Million) Forecast by Disease, 2018 to 2033 Table 14: Latin America Market Value (US$ Million) Forecast by Species, 2018 to 2033 Table 15: Latin America Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 16: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 17: Europe Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 18: Europe Market Value (US$ Million) Forecast by Disease, 2018 to 2033 Table 19: Europe Market Value (US$ Million) Forecast by Species, 2018 to 2033 Table 20: Europe Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 21: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: South Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 23: South Asia Market Value (US$ Million) Forecast by Disease, 2018 to 2033 Table 24: South Asia Market Value (US$ Million) Forecast by Species, 2018 to 2033 Table 25: South Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 26: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 27: East Asia Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 28: East Asia Market Value (US$ Million) Forecast by Disease, 2018 to 2033 Table 29: East Asia Market Value (US$ Million) Forecast by Species, 2018 to 2033 Table 30: East Asia Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 31: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 32: Oceania Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 33: Oceania Market Value (US$ Million) Forecast by Disease, 2018 to 2033 Table 34: Oceania Market Value (US$ Million) Forecast by Species, 2018 to 2033 Table 35: Oceania Market Value (US$ Million) Forecast by End User, 2018 to 2033 Table 36: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 37: MEA Market Value (US$ Million) Forecast by Product, 2018 to 2033 Table 38: MEA Market Value (US$ Million) Forecast by Disease, 2018 to 2033 Table 39: MEA Market Value (US$ Million) Forecast by Species, 2018 to 2033 Table 40: MEA Market Value (US$ Million) Forecast by End User, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Product, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Disease, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Species, 2023 to 2033 Figure 4: Global Market Value (US$ Million) by End User, 2023 to 2033 Figure 5: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 6: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 9: Global Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 10: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 11: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 12: Global Market Value (US$ Million) Analysis by Disease, 2018 to 2033 Figure 13: Global Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 14: Global Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 15: Global Market Value (US$ Million) Analysis by Species, 2018 to 2033 Figure 16: Global Market Value Share (%) and BPS Analysis by Species, 2023 to 2033 Figure 17: Global Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033 Figure 18: Global Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 19: Global Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 20: Global Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 21: Global Market Attractiveness by Product, 2023 to 2033 Figure 22: Global Market Attractiveness by Disease, 2023 to 2033 Figure 23: Global Market Attractiveness by Species, 2023 to 2033 Figure 24: Global Market Attractiveness by End User, 2023 to 2033 Figure 25: Global Market Attractiveness by Region, 2023 to 2033 Figure 26: North America Market Value (US$ Million) by Product, 2023 to 2033 Figure 27: North America Market Value (US$ Million) by Disease, 2023 to 2033 Figure 28: North America Market Value (US$ Million) by Species, 2023 to 2033 Figure 29: North America Market Value (US$ Million) by End User, 2023 to 2033 Figure 30: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 37: North America Market Value (US$ Million) Analysis by Disease, 2018 to 2033 Figure 38: North America Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 39: North America Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 40: North America Market Value (US$ Million) Analysis by Species, 2018 to 2033 Figure 41: North America Market Value Share (%) and BPS Analysis by Species, 2023 to 2033 Figure 42: North America Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033 Figure 43: North America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 44: North America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 45: North America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 46: North America Market Attractiveness by Product, 2023 to 2033 Figure 47: North America Market Attractiveness by Disease, 2023 to 2033 Figure 48: North America Market Attractiveness by Species, 2023 to 2033 Figure 49: North America Market Attractiveness by End User, 2023 to 2033 Figure 50: North America Market Attractiveness by Country, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) by Product, 2023 to 2033 Figure 52: Latin America Market Value (US$ Million) by Disease, 2023 to 2033 Figure 53: Latin America Market Value (US$ Million) by Species, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) by End User, 2023 to 2033 Figure 55: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 56: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 59: Latin America Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 60: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 62: Latin America Market Value (US$ Million) Analysis by Disease, 2018 to 2033 Figure 63: Latin America Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 65: Latin America Market Value (US$ Million) Analysis by Species, 2018 to 2033 Figure 66: Latin America Market Value Share (%) and BPS Analysis by Species, 2023 to 2033 Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033 Figure 68: Latin America Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 69: Latin America Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 70: Latin America Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 71: Latin America Market Attractiveness by Product, 2023 to 2033 Figure 72: Latin America Market Attractiveness by Disease, 2023 to 2033 Figure 73: Latin America Market Attractiveness by Species, 2023 to 2033 Figure 74: Latin America Market Attractiveness by End User, 2023 to 2033 Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 76: Europe Market Value (US$ Million) by Product, 2023 to 2033 Figure 77: Europe Market Value (US$ Million) by Disease, 2023 to 2033 Figure 78: Europe Market Value (US$ Million) by Species, 2023 to 2033 Figure 79: Europe Market Value (US$ Million) by End User, 2023 to 2033 Figure 80: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 81: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 82: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 83: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 84: Europe Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 85: Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 86: Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 87: Europe Market Value (US$ Million) Analysis by Disease, 2018 to 2033 Figure 88: Europe Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 89: Europe Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 90: Europe Market Value (US$ Million) Analysis by Species, 2018 to 2033 Figure 91: Europe Market Value Share (%) and BPS Analysis by Species, 2023 to 2033 Figure 92: Europe Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033 Figure 93: Europe Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 94: Europe Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 95: Europe Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 96: Europe Market Attractiveness by Product, 2023 to 2033 Figure 97: Europe Market Attractiveness by Disease, 2023 to 2033 Figure 98: Europe Market Attractiveness by Species, 2023 to 2033 Figure 99: Europe Market Attractiveness by End User, 2023 to 2033 Figure 100: Europe Market Attractiveness by Country, 2023 to 2033 Figure 101: South Asia Market Value (US$ Million) by Product, 2023 to 2033 Figure 102: South Asia Market Value (US$ Million) by Disease, 2023 to 2033 Figure 103: South Asia Market Value (US$ Million) by Species, 2023 to 2033 Figure 104: South Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 105: South Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 106: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 107: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 108: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 109: South Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 110: South Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 111: South Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 112: South Asia Market Value (US$ Million) Analysis by Disease, 2018 to 2033 Figure 113: South Asia Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 114: South Asia Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 115: South Asia Market Value (US$ Million) Analysis by Species, 2018 to 2033 Figure 116: South Asia Market Value Share (%) and BPS Analysis by Species, 2023 to 2033 Figure 117: South Asia Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033 Figure 118: South Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 119: South Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 120: South Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 121: South Asia Market Attractiveness by Product, 2023 to 2033 Figure 122: South Asia Market Attractiveness by Disease, 2023 to 2033 Figure 123: South Asia Market Attractiveness by Species, 2023 to 2033 Figure 124: South Asia Market Attractiveness by End User, 2023 to 2033 Figure 125: South Asia Market Attractiveness by Country, 2023 to 2033 Figure 126: East Asia Market Value (US$ Million) by Product, 2023 to 2033 Figure 127: East Asia Market Value (US$ Million) by Disease, 2023 to 2033 Figure 128: East Asia Market Value (US$ Million) by Species, 2023 to 2033 Figure 129: East Asia Market Value (US$ Million) by End User, 2023 to 2033 Figure 130: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 131: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 132: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 134: East Asia Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 135: East Asia Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 137: East Asia Market Value (US$ Million) Analysis by Disease, 2018 to 2033 Figure 138: East Asia Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 139: East Asia Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 140: East Asia Market Value (US$ Million) Analysis by Species, 2018 to 2033 Figure 141: East Asia Market Value Share (%) and BPS Analysis by Species, 2023 to 2033 Figure 142: East Asia Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033 Figure 143: East Asia Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 144: East Asia Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 145: East Asia Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 146: East Asia Market Attractiveness by Product, 2023 to 2033 Figure 147: East Asia Market Attractiveness by Disease, 2023 to 2033 Figure 148: East Asia Market Attractiveness by Species, 2023 to 2033 Figure 149: East Asia Market Attractiveness by End User, 2023 to 2033 Figure 150: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 151: Oceania Market Value (US$ Million) by Product, 2023 to 2033 Figure 152: Oceania Market Value (US$ Million) by Disease, 2023 to 2033 Figure 153: Oceania Market Value (US$ Million) by Species, 2023 to 2033 Figure 154: Oceania Market Value (US$ Million) by End User, 2023 to 2033 Figure 155: Oceania Market Value (US$ Million) by Country, 2023 to 2033 Figure 156: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 157: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 158: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 159: Oceania Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 160: Oceania Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 161: Oceania Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 162: Oceania Market Value (US$ Million) Analysis by Disease, 2018 to 2033 Figure 163: Oceania Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 164: Oceania Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 165: Oceania Market Value (US$ Million) Analysis by Species, 2018 to 2033 Figure 166: Oceania Market Value Share (%) and BPS Analysis by Species, 2023 to 2033 Figure 167: Oceania Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033 Figure 168: Oceania Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 169: Oceania Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 170: Oceania Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 171: Oceania Market Attractiveness by Product, 2023 to 2033 Figure 172: Oceania Market Attractiveness by Disease, 2023 to 2033 Figure 173: Oceania Market Attractiveness by Species, 2023 to 2033 Figure 174: Oceania Market Attractiveness by End User, 2023 to 2033 Figure 175: Oceania Market Attractiveness by Country, 2023 to 2033 Figure 176: MEA Market Value (US$ Million) by Product, 2023 to 2033 Figure 177: MEA Market Value (US$ Million) by Disease, 2023 to 2033 Figure 178: MEA Market Value (US$ Million) by Species, 2023 to 2033 Figure 179: MEA Market Value (US$ Million) by End User, 2023 to 2033 Figure 180: MEA Market Value (US$ Million) by Country, 2023 to 2033 Figure 181: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 184: MEA Market Value (US$ Million) Analysis by Product, 2018 to 2033 Figure 185: MEA Market Value Share (%) and BPS Analysis by Product, 2023 to 2033 Figure 186: MEA Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033 Figure 187: MEA Market Value (US$ Million) Analysis by Disease, 2018 to 2033 Figure 188: MEA Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033 Figure 189: MEA Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033 Figure 190: MEA Market Value (US$ Million) Analysis by Species, 2018 to 2033 Figure 191: MEA Market Value Share (%) and BPS Analysis by Species, 2023 to 2033 Figure 192: MEA Market Y-o-Y Growth (%) Projections by Species, 2023 to 2033 Figure 193: MEA Market Value (US$ Million) Analysis by End User, 2018 to 2033 Figure 194: MEA Market Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 195: MEA Market Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 196: MEA Market Attractiveness by Product, 2023 to 2033 Figure 197: MEA Market Attractiveness by Disease, 2023 to 2033 Figure 198: MEA Market Attractiveness by Species, 2023 to 2033 Figure 199: MEA Market Attractiveness by End User, 2023 to 2033 Figure 200: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports